BioSpace News Archive

Business

Polyphor and the University of Zurich receive an award from Innosuisse to accelerate the development of a new class of antibiotics inhibiting the LPS transport pathway

Polyphor and the University of Zurich receive an award from Innosuisse to accelerate the development of a new class of antibiotics inhibiting the LPS transport pathway

May 29, 2019
·
4 min read
Deals

ASIT biotech: Publishes the Documents Relating to the Extraordinary General Shareholders’ Meeting on 28 June 2019

Upon approval by the shareholders, ASIT biotech expects to raise between €9M and €12M of convertible notes to finance its focused development

May 29, 2019
·
5 min read
Deals

Ordinary General Meeting of Shareholders of Probiodrug AG - 29 May 2019

Probiodrug AG, announces that its shareholders approved all resolutions proposed by the Company’s Management and Supervisory Board at the Company’s Annual General Meeting which took place on Wednesday, May 29, 2019

May 29, 2019
·
4 min read
Royal Manchester Children’s Hospital MPSIIIA patient receives world’s first gene therapy treatment for life-limiting genetic condition

A two-year old patient at the Royal Manchester Children’s Hospital (RMCH) is the first in the world to receive a pioneering new ex vivogene therapy treatment using lentiviral vector-modified autologous stem cells for the rare and life-limiting genetic condition, Mucopolysaccharidosis IIIA (MPSIIIA).

May 29, 2019
·
5 min read
Job Trends

APEX Biologix Expands Its XCELL Product Line to Include a Bone Marrow Concentration Device Designed to Maximize Concentrations of Mesenchymal Stem Cells

APEX Biologix is proud to introduce an exciting new bone marrow concentration device designed to maximize mesenchymal stem cell numbers from bone marrow aspirate.

May 29, 2019
·
1 min read
Business

Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award

Ultragenyx Pharmaceutical Inc. announced that the Biotechnology Innovation Organization (BIO) has awarded this year’s Henri A. Termeer Biotechnology Visionary Award to Emil D. Kakkis, M.D., Ph.D., Chief Executive Officer, President and founder of Ultragenyx.

May 29, 2019
·
4 min read
Business

Neuroscientists at Emory University Terminated Following Scrutiny of Chinese Funding Ties

The faculty members terminated at Emory University said they fully disclosed their funding sources and raised concerns over anti-Chinese sentiments, according to reports.

May 29, 2019
·
3 min read
·
Alex Keown
Business

COTA and FDA Partner on Real-World Evidence Program in Breast Cancer

The collaboration will establish a study protocol with an initial focus on breast cancer to provide the regulatory agency with information on the evolving treatment landscape, including insight on treatment variation within defined subpopulations of patients with the disease.

May 29, 2019
·
3 min read
·
Alex Keown
FDA

Medtronic Gains U.S. FDA Clearance for New Catheter System for HIS Bundle Pacing

Medtronic plc announced U.S. Food and Drug Administration clearance and commercial launch for the SelectSite C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing.

May 29, 2019
·
2 min read
Business

Amicus and Penn Broaden Gene Therapy Collaboration to Include 12 More Rare Diseases

The deal broadens their work together from three to six programs for rare genetic diseases, as well as rights to collaborative R&D of novel gene therapies for lysosomal disorders and 12 additional rare diseases.

May 29, 2019
·
3 min read
·
Mark Terry